Impact of obesity and breathlessness on MACE outcomes within HFpEF: results from the UK Biobank

31 August 2025 (17:30 - 17:40)

Organised by:

Video

Abstract

Sign in to view the resources

Slides

About the speaker

Professor Masliza Mahmod

Perspectum Ltd, Oxford (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail

Cardiac amyloidosis and heart failure phenotypes: a prognostic study of systolic function markers

Assistant Professor A. Zaroui (Creteil, FR)

Abstract Slides Video

Presentation thumbnail

The impact of left ventricular reverse remodeling on asymptomatic structual heart disease

Doctor K. Tanaka (Niigata, JP)

Abstract Slides Video

Presentation thumbnail

Proteomic profiling of circulating exosome identifies CAPG as a key molecule associated with clinical outcomes in heart failure

Doctor S. Okochi (Fukushima, JP)

Abstract Slides Video

Presentation thumbnail

Mismatch between lead I from the 12-Lead ECG and smartwatch ECG: can AI models adapt for left ventricular systolic dysfunction prediction?

Mr J. Jang (Seoul, KR)

Abstract Slides Video

Presentation thumbnail

Identification of biomarkers for right ventricular dysfunction in dilated cardiomyopathy using urinary proteomics and machine learning

Doctor J. Zhang (Beijing, CN)

Abstract Slides Video

Access the full session

Session thumbnail

Mechanisms of heart failure: emerging evidence

The Event

Event poster

ESC Congress 2025

31 August 2025 17:30 CET

You may be interested in

Congress Presentation

The obesity phenotype of HFpEF

Congress Session

Challenges of managing obesity in cardiovascular disease

Congress Presentation

HFpEF and obesity: key concepts from evaluation to treatment

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources